Yang, A., & McKeon, F. (2000). P63 and P73: P53 mimics, menaces and more. Nature Reviews Molecular Cell Biology, 1(3), 199–207. https://doi.org/10.1038/35043127
CAS Article PubMed Google Scholar
Graziano, V., & De Laurenzi, V. (2011). Role of p63 in cancer development. Biochimica et Biophysica Acta, 1816(1), 57–66. https://doi.org/10.1016/j.bbcan.2011.04.002
CAS Article PubMed Google Scholar
Su, X., Chakravarti, D., & Flores, E. R. (2013). p63 steps into the limelight: Crucial roles in the suppression of tumorigenesis and metastasis. Nature Reviews Cancer, 13(2), 136–143. https://doi.org/10.1038/nrc3446
CAS Article PubMed PubMed Central Google Scholar
Stiewe, T. (2007). The p53 family in differentiation and tumorigenesis. Nature Reviews Cancer, 7(3), 165–168. https://doi.org/10.1038/nrc2072
CAS Article PubMed Google Scholar
Li, Y., & Prives, C. (2007). Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function? Oncogene, 26(15), 2220–2225. https://doi.org/10.1038/sj.onc.1210311
CAS Article PubMed Google Scholar
Ramos, H., Raimundo, L., & Saraiva, L. (2020). p73: From the p53 shadow to a major pharmacological target in anticancer therapy. Pharmacological Research, 162, 105245. https://doi.org/10.1016/j.phrs.2020.105245
CAS Article PubMed Google Scholar
Stiewe, T., Theseling, C. C., & Pützer, B. M. (2002). Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: Implications for tumorigenesis. Journal of Biological Chemistry, 277(16), 14177–14185. https://doi.org/10.1074/jbc.M200480200
CAS Article PubMed Google Scholar
Kartasheva, N. N., Contente, A., Lenz-Stöppler, C., Roth, J., & Dobbelstein, M. (2002). p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop. Oncogene, 21(31), 4715–4727. https://doi.org/10.1038/sj.onc.1205584
CAS Article PubMed Google Scholar
Zaika, A. I., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M., et al. (2002). DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. Journal of Experimental Medicine, 196(6), 765–780. https://doi.org/10.1084/jem.20020179
CAS Article PubMed PubMed Central Google Scholar
Grob, T. J., Novak, U., Maisse, C., Barcaroli, D., Lüthi, A. U., Pirnia, F., et al. (2001). Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death and Differentiation, 8(12), 1213–1223. https://doi.org/10.1038/sj.cdd.4400962
CAS Article PubMed Google Scholar
Marabese, M., Vikhanskaya, F., & Broggini, M. (2007). p73: A chiaroscuro gene in cancer. European Journal of Cancer, 43(9), 1361–1372. https://doi.org/10.1016/j.ejca.2007.01.042
CAS Article PubMed Google Scholar
Tomasini, R., Tsuchihara, K., Wilhelm, M., Fujitani, M., Rufini, A., Cheung, C. C., et al. (2008). TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes and Development, 22(19), 2677–2691. https://doi.org/10.1101/gad.1695308
CAS Article PubMed PubMed Central Google Scholar
Wilhelm, M. T., Rufini, A., Wetzel, M. K., Tsuchihara, K., Inoue, S., Tomasini, R., et al. (2010). Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. Genes and Development, 24(6), 549–560. https://doi.org/10.1101/gad.1873910
CAS Article PubMed PubMed Central Google Scholar
Stiewe, T., Zimmermann, S., Frilling, A., Esche, H., & Pützer, B. M. (2002). Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Research, 62(13), 3598–3602.
Steder, M., Alla, V., Meier, C., Spitschak, A., Pahnke, J., Fürst, K., et al. (2013). DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling. Cancer Cell, 24(4), 512–527. https://doi.org/10.1016/j.ccr.2013.08.023
CAS Article PubMed Google Scholar
Lunghi, P., Costanzo, A., Mazzera, L., Rizzoli, V., Levrero, M., & Bonati, A. (2009). The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting. Clinical Cancer Research, 15(21), 6495–6502. https://doi.org/10.1158/1078-0432.CCR-09-1229
CAS Article PubMed Google Scholar
Amelio, I., Inoue, S., Markert, E. K., Levine, A. J., Knight, R. A., Mak, T. W., et al. (2015). TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation. Proc Natl Acad Sci U S A, 112(1), 226–231. https://doi.org/10.1073/pnas.1410609111
CAS Article PubMed Google Scholar
Stantic, M., Sakil, H. A., Zirath, H., Fang, T., Sanz, G., Fernandez-Woodbridge, A., et al. (2015). TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activity. Proc Natl Acad Sci U S A, 112(1), 220–225. https://doi.org/10.1073/pnas.1421697112
CAS Article PubMed Google Scholar
Dulloo, I., Phang, B. H., Othman, R., Tan, S. Y., Vijayaraghavan, A., Goh, L. K., et al. (2015). Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptome. Nature Cell Biology, 17(4), 511–523. https://doi.org/10.1038/ncb3130
CAS Article PubMed Google Scholar
López-Ferreras, L., Martínez-García, N., Maeso-Alonso, L., Martín-López, M., Díez-Matilla, Á., Villoch-Fernandez, J., et al. (2021). Deciphering the Nature of Trp73 Isoforms in Mouse Embryonic Stem Cell Models: Generation of Isoform-Specific. Cancers (Basel), 13, 13. https://doi.org/10.3390/cancers13133182
Gui, P., & Bivona, T. G. (2022). Evolution of metastasis: New tools and insights. Trends Cancer, 8(2), 98–109. https://doi.org/10.1016/j.trecan.2021.11.002
CAS Article PubMed Google Scholar
Merlo, L. M., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006). Cancer as an evolutionary and ecological process. Nature Reviews Cancer, 6(12), 924–935. https://doi.org/10.1038/nrc2013
CAS Article PubMed Google Scholar
McGranahan, N., & Swanton, C. (2017). Clonal heterogeneity and tumor evolution: Past, present, and the future. Cell, 168(4), 613–628. https://doi.org/10.1016/j.cell.2017.01.018
CAS Article PubMed Google Scholar
Birkbak, N. J., & McGranahan, N. (2020). Cancer genome evolutionary trajectories in metastasis. Cancer Cell, 37(1), 8–19. https://doi.org/10.1016/j.ccell.2019.12.004
CAS Article PubMed Google Scholar
Turajlic, S., & Swanton, C. (2016). Metastasis as an evolutionary process. Science, 352(6282), 169–175. https://doi.org/10.1126/science.aaf2784
CAS Article PubMed Google Scholar
Amirouchene-Angelozzi, N., Swanton, C., & Bardelli, A. (2017). Tumor evolution as a therapeutic target. Cancer Discov, https://doi.org/10.1158/2159-8290.Cd-17-0343
Rodrigues, P., Patel, S. A., Harewood, L., Olan, I., Vojtasova, E., Syafruddin, S. E., et al. (2018). NF-κB-dependent lymphoid enhancer co-option promotes renal carcinoma metastasis. Cancer Discovery, 8(7), 850–865. https://doi.org/10.1158/2159-8290.Cd-17-1211
CAS Article PubMed PubMed Central Google Scholar
Logotheti, S., Marquardt, S., Richter, C., Sophie Hain, R., Murr, N., Takan, I., et al. (2020). Neural networks recapitulation by cancer cells promotes disease progression: a novel role of p73 isoforms in cancer-neuronal crosstalk. Cancers, 12, 12. https://doi.org/10.3390/cancers12123789
Patel, S. A., Rodrigues, P., Wesolowski, L., & Vanharanta, S. (2021). Genomic control of metastasis. British Journal of Cancer, 124(1), 3–12. https://doi.org/10.1038/s41416-020-01127-6
CAS Article PubMed Google Scholar
Kerosuo, L., & Bronner-Fraser, M. (2012). What is bad in cancer is good in the embryo: Importance of EMT in neural crest development. Seminars in Cell & Developmental Biology, 23(3), 320–332. https://doi.org/10.1016/j.semcdb.2012.03.010
Rousseaux, S., Debernardi, A., Jacquiau, B., Vitte, A. L., Vesin, A., Nagy-Mignotte, H., et al. (2013). Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med, 5(186), 186ra166. https://doi.org/10.1126/scitranslmed.3005723
Richter, C., Marquardt, S., Li, F., Spitschak, A., Murr, N., Edelhäuser, B. A. H., et al. (2019). Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness. Journal of Experimental & Clinical Cancer Research, 38(1), 292. https://doi.org/10.1186/s13046-019-1286-9
Costanzo, V., Bardelli, A., Siena, S., & Abrignani, S. (2018). Exploring the links between cancer and placenta development. Open Biol, 8, 6. https://doi.org/10.1098/rsob.180081
Marquardt, S., Pavlopoulou, A., Takan, I., Dhar, P., Pützer, B. M., & Logotheti, S. (2021). A systems-based key innovation-driven approach infers co-option of jaw developmental programs during cancer progression. Front Cell Dev Biol, 9, 682619. https://doi.org/10.3389/fcell.2021.682619
Article PubMed PubMed Central Google Scholar
Yılmaz, H., Toy, H. I., Marquardt, S., Karakülah, G., Küçük, C., Kontou, P. I., et al. (2021). In silico methods for the identification of diagnostic and favorable prognostic markers in acute myeloid leukemia. International Journal of Molecular Sciences, 22, 17. https://doi.org/10.3390/ijms22179601
Kerbel, R. S. (2000). Tumor angiogenesis: Past, present and the near future. Carcinogenesis, 21(3), 505–515. https://doi.org/10.1093/carcin/21.3.505
CAS Article PubMed Google Scholar
Cervantes-Villagrana, R. D., Albores-García, D., Cervantes-Villagrana, A. R., & García-Acevez, S. J. (2020). Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduction and Targeted Therapy, 5
留言 (0)